• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC UNK_NAVISTAR THERMOCOOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC UNK_NAVISTAR THERMOCOOL Back to Search Results
Catalog Number UNK_NAVISTAR THERMOCOOL
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Pseudoaneurysm (2605)
Event Date 04/30/2019
Event Type  Injury  
Manufacturer Narrative
Manufacturer's ref.No : (b)(4).No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Biosense webster manufacturer's report numbers: 2029046-2021-00742 and 2029046-2021-00743.Are related to the same incident.
 
Event Description
This complaint is from a literature source.The following complications were reported in this publication: it was reported that 1 patient underwent catheter ablation of atrial fibrillation and suffered femoral pseudoaneurysm.Intervention was thrombin injection.Model and catalog number are not available, but the suspected device is navistar thermocool smarttouch.Other biosense webster devices that were also used in this study: lasso, carto 3 non-biosense webster devices that were also used in this study: 8.5-fr long sheaths(st judes).Publication details: title: costs and long-term outcomes following pulmonary vein isolation for atrial fibrillation in elderly patients using second-generation cryoballoon vs.Open-irrigated radiofrequency in china.Objective: limited comparative data are available regarding catheter ablation (ca) of atrial fibrillation (af) using secondgeneration cryoballoon (cb-2) vs.Radiofrequency (rf) ablation in elderly patients (> 75 years old.The present study aimed to compare the costs and clinical outcomes in elderly patients using these two strategies.Methods: elderly patients with symptomatic drug-refractory paroxysmal/short-lasting persistent af were included in the study.Pulmonary vein isolation (pvi) was performed in all patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_NAVISTAR THERMOCOOL
Type of Device
UNK
Manufacturer (Section D)
BIOSENSE WEBSTER INC
33 technology drive
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
gabriel alfageme
31 technology drive
irvine, CA 92618
949789-868
MDR Report Key11803669
MDR Text Key249975068
Report Number2029046-2021-00741
Device Sequence Number1
Product Code OAD
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Reporter Occupation Physician
Type of Report Initial
Report Date 04/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_NAVISTAR THERMOCOOL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/21/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
8.5-FR LONG SHEATHS(ST JUDES); UNK_CARTO 3; UNK_LASSO
Patient Outcome(s) Required Intervention;
Patient Age79 YR
-
-